Dr. Pritlove is a critical qualitative methodologist and health services researcher with expertise in Equity, Diversity and Inclusion (EDI). She employs patient-oriented research methodologies in her work on Type 1 Diabetes, partnering with patients and communities to improve the quality, safety, access, and person-centered nature of diabetes care.

He leads a multidisciplinary team of research staff and trainees focused on rigorously drawing from – and contributing to – behavioural and implementation science to support the health and well-being of patients, the public, and supporting health providers in the health care system to provide high quality care. This group partners with interest holders including patients, people with lived experience and health system decision makers and health providers, and with a strong commitment to equity-focused research.

Dr. Poitras is an expert in knowledge mobilization and patient-engagement in the context of primary care of chronic diseases. Her research is focused on nursing practice, primary care health service organization, patient-reported measures, and patient engagement. She is co-leading a national initiative funded by Service Canada to support the development of the scope of practice of primary care nurses in family medicine clinics.

Dr. Monica Parry is a Nurse Practitioner (Adult) with over 35 years of cardiovascular (CV) clinical experience. Her clinical expertise has laid the foundation for a program of research to reduce the burden of CV disease and its complications. Dr. Parry is a member of the Banting & Best Diabetes Centre and is Core Faculty and a Collaborating Investigator with the Collaborative Program in Resuscitation Science, Faculty of Medicine, University of Toronto. She is interested in sex and gender issues and is currently leading a research team to develop and test at heart: A WebApp for Women with Heart Disease.

Dr. Bruce Perkins’ research platform, research leadership, clinical practice, and advocacy work has focused entirely on strategies to improve the lives of those, like himself, living with type 1 diabetes. Using cohort and trial methods, his research has focused on; 1) early biomarkers and mechanisms of diabetes complications, and 2) complications prevention through artificial pancreas technologies and add-on-to-insulin drug therapies.